Soluble ST2 in coronary artery disease: Clinical biomarkers and treatment guidance

Soluble ST2 in coronary artery disease: Clinical biomarkers and treatment guidance

The IL-33/ST2 L signaling pathway is involved in the pathophysiological processes of several diseases and mainly exerts anti-inflammatory and antifibrotic effects. Soluble suppression of tumorigenicity 2 (sST2), which serves as a competitive inhibitory molecule of this pathway, is a member of the in...

Full description

Bibliographic Details
Main Authors: Junyan Zhang, Zhongxiu Chen, Min Ma, Yong He
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
sST2
coronary artery disease
myocardial infarction
LVR
management
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.924461/full

Similar Items

Similar Items